Attached files
| file | filename |
|---|---|
| EX-32.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE AND PRINCIPAL FINANCIAL OFFICERS - LEXICON PHARMACEUTICALS, INC. | exh321certificationofprinc.htm |
| EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - LEXICON PHARMACEUTICALS, INC. | exh312certificationofprinc.htm |
| EXCEL - IDEA: XBRL DOCUMENT - LEXICON PHARMACEUTICALS, INC. | Financial_Report.xls |
| 10-K - FORM 10-K - LEXICON PHARMACEUTICALS, INC. | form10k12312014.htm |
| EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - LEXICON PHARMACEUTICALS, INC. | exh311certificationofprinc.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) | Registration Statements (Form S-8 Nos. 333-41532, 333-168678 and 333-183020) pertaining to the Equity Incentive Plan and to the Non-Employee Directors' Equity Incentive Plan of Lexicon Pharmaceuticals, Inc., and |
(2) | Registration Statements (Form S-3 Nos. 333-182859, 333-198493 and 333-200699) of Lexicon Pharmaceuticals, Inc. |
of our reports dated March 12, 2015, with respect to the consolidated financial statements of Lexicon Pharmaceuticals, Inc. and the effectiveness of internal control over financial reporting of Lexicon Pharmaceuticals, Inc., included in this annual report (Form 10-K) of Lexicon Pharmaceuticals, Inc. for the year ended December 31, 2014.
/s/ Ernst & Young LLP
Houston, Texas
March 12, 2015